These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17393134)

  • 1. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study.
    Hayashino Y; Fukuhara S; Akiba T; Akizawa T; Asano Y; Saito A; Bragg-Gresham JL; Ramirez SP; Port FK; Kurokawa K
    Diabetologia; 2007 Jun; 50(6):1170-7. PubMed ID: 17393134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
    Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
    Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.
    Shurraw S; Majumdar SR; Thadhani R; Wiebe N; Tonelli M;
    Am J Kidney Dis; 2010 May; 55(5):875-84. PubMed ID: 20346561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low health-related quality of life is associated with all-cause mortality in patients with diabetes on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study.
    Hayashino Y; Fukuhara S; Akiba T; Akizawa T; Asano Y; Saito S; Kurokawa K
    Diabet Med; 2009 Sep; 26(9):921-7. PubMed ID: 19719714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
    Ishimura E; Okuno S; Kitatani K; Kim M; Shoji T; Nakatani T; Inaba M; Nishizawa Y
    Diabetologia; 2002 Oct; 45(10):1446-8. PubMed ID: 12378387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis.
    Shima K; Komatsu M; Kawahara K; Minaguchi J; Kawashima S
    Nephrology (Carlton); 2010 Sep; 15(6):632-8. PubMed ID: 20883284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).
    Landman GW; van Hateren KJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Br J Gen Pract; 2010 Mar; 60(572):172-5. PubMed ID: 20202363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K.
    Adler A; Casula A; Steenkamp R; Fogarty D; Wilkie M; Tomlinson L; Nitsch D; Roderick P; Tomson CR
    Diabetes Care; 2014; 37(5):1304-11. PubMed ID: 24574356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy.
    Murakami R; Murakami S; Tsushima R; Ueda C; Mikami K; Ebina T; Kumasaka R; Nakamura N; Okumura K
    Nephrol Dial Transplant; 2008 Jan; 23(1):315-20. PubMed ID: 17956892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
    Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
    Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
    Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
    Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
    Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
    Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes.
    Rhee CM; Kovesdy CP; Ravel VA; Streja E; Brunelli SM; Soohoo M; Sumida K; Molnar MZ; Brent GA; Nguyen DV; Kalantar-Zadeh K
    Diabetes Care; 2017 Aug; 40(8):1050-1057. PubMed ID: 28592525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Hoshino J; Larkina M; Karaboyas A; Bieber BA; Ubara Y; Takaichi K; Akizawa T; Akiba T; Fukuhara S; Pisoni RL; Saito A; Robinson BM
    Kidney Int; 2017 Aug; 92(2):497-503. PubMed ID: 28396123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
    Oomichi T; Emoto M; Tabata T; Morioka T; Tsujimoto Y; Tahara H; Shoji T; Nishizawa Y
    Diabetes Care; 2006 Jul; 29(7):1496-500. PubMed ID: 16801568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
    Sugawara A; Kawai K; Motohashi S; Saito K; Kodama S; Yachi Y; Hirasawa R; Shimano H; Yamazaki K; Sone H
    Diabetologia; 2012 Aug; 55(8):2128-31. PubMed ID: 22580991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemoglobin A(1c) , acute hyperglycaemia and short-term prognosis in patients without diabetes following acute ST-segment elevation myocardial infarction.
    Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Li JD
    Diabet Med; 2012 Dec; 29(12):1493-500. PubMed ID: 22413832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.
    Rodríguez-Segade S; Rodríguez J; García López JM; Casanueva FF; Camiña F
    Diabet Med; 2012 Dec; 29(12):1562-6. PubMed ID: 22913483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.